Evidence map›Paper›PMID 34073611›Full record

ReviewInternational journal of molecular sciences2021

Next-Generation Sequencing Applications for Inherited Retinal Diseases.

Adrian Dockery, Laura Whelan, Pete Humphries, G Jane Farrar

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adrian DockeryThe School of Genetics & Microbiology, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0002-3423-2542
Laura WhelanThe School of Genetics & Microbiology, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0002-0537-4349
Pete HumphriesThe School of Genetics & Microbiology, Trinity College Dublin, Dublin 2, Ireland.
G Jane FarrarThe School of Genetics & Microbiology, Trinity College Dublin, Dublin 2, Ireland.

Funding

Fighting Blindness Ireland FB16FARFighting Blindness Ireland FB18CREHealth Research Charities Ireland HRCI; MRCG-2013-8, MRCG-2016-14Science Foundation Ireland SFI; 16/1A/4452The Health Research Board of Ireland HRB; POR/2010/97The Irish Research Council IRC; GOIPG/2017/1631
6 · The paper itself

Abstract

Inherited retinal diseases (IRDs) represent a collection of phenotypically and genetically diverse conditions. IRDs phenotype(s) can be isolated to the eye or can involve multiple tissues. These conditions are associated with diverse forms of inheritance, and variants within the same gene often can be associated with multiple distinct phenotypes. Such aspects of the IRDs highlight the difficulty met when establishing a genetic diagnosis in patients. Here we provide an overview of cutting-edge next-generation sequencing techniques and strategies currently in use to maximise the effectivity of IRD gene screening. These techniques have helped researchers globally to find elusive causes of IRDs, including copy number variants, structural variants, new IRD genes and deep intronic variants, among others. Resolving a genetic diagnosis with thorough testing enables a more accurate diagnosis and more informed prognosis and should also provide information on inheritance patterns which may be of particular interest to patients of a child-bearing age. Given that IRDs are heritable conditions, genetic counselling may be offered to help inform family planning, carrier testing and prenatal screening. Additionally, a verified genetic diagnosis may enable access to appropriate clinical trials or approved medications that may be available for the condition.

Indexed as

Genetic CounselingGenetic Diseases, InbornGenetic TestingHigh-Throughput Nucleotide SequencingPrenatal DiagnosisRetinal DiseasesHumansdiagnosticseyegenetic diagnosisgenomicsinherited retinal diseasemacularare diseaseretinasequencingvariant interpretation

Identifiers

PMID34073611
PMCPMC8198572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.